JP2012524902A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524902A5
JP2012524902A5 JP2012507255A JP2012507255A JP2012524902A5 JP 2012524902 A5 JP2012524902 A5 JP 2012524902A5 JP 2012507255 A JP2012507255 A JP 2012507255A JP 2012507255 A JP2012507255 A JP 2012507255A JP 2012524902 A5 JP2012524902 A5 JP 2012524902A5
Authority
JP
Japan
Prior art keywords
mer unit
seq
identity
heterodimer
mer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012507255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524902A (ja
JP5882196B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/030836 external-priority patent/WO2010123720A1/en
Publication of JP2012524902A publication Critical patent/JP2012524902A/ja
Publication of JP2012524902A5 publication Critical patent/JP2012524902A5/ja
Application granted granted Critical
Publication of JP5882196B2 publication Critical patent/JP5882196B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012507255A 2009-04-23 2010-04-13 アディポネクチン受容体フラグメントの単量体及び二量体形態ならびに使用の方法 Expired - Fee Related JP5882196B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17197909P 2009-04-23 2009-04-23
US61/171,979 2009-04-23
PCT/US2010/030836 WO2010123720A1 (en) 2009-04-23 2010-04-13 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015209307A Division JP2016035470A (ja) 2009-04-23 2015-10-23 アディポネクチン受容体フラグメントの単量体及び二量体形態ならびに使用の方法

Publications (3)

Publication Number Publication Date
JP2012524902A JP2012524902A (ja) 2012-10-18
JP2012524902A5 true JP2012524902A5 (https=) 2013-04-04
JP5882196B2 JP5882196B2 (ja) 2016-03-09

Family

ID=43011406

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012507255A Expired - Fee Related JP5882196B2 (ja) 2009-04-23 2010-04-13 アディポネクチン受容体フラグメントの単量体及び二量体形態ならびに使用の方法
JP2015209307A Pending JP2016035470A (ja) 2009-04-23 2015-10-23 アディポネクチン受容体フラグメントの単量体及び二量体形態ならびに使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015209307A Pending JP2016035470A (ja) 2009-04-23 2015-10-23 アディポネクチン受容体フラグメントの単量体及び二量体形態ならびに使用の方法

Country Status (6)

Country Link
US (3) US8865648B2 (https=)
EP (2) EP3444611A1 (https=)
JP (2) JP5882196B2 (https=)
CN (1) CN102388308B (https=)
ES (1) ES2693165T3 (https=)
WO (1) WO2010123720A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123720A1 (en) 2009-04-23 2010-10-28 Siemens Healthcare Diagnostics Inc. Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
CA2735578C (en) 2008-08-12 2018-10-23 Zinfandel Pharmaceuticals, Inc. Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants
US8846315B2 (en) 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
EP2391377A2 (en) 2009-02-02 2011-12-07 Ramot at Tel-Aviv University Ltd. Peptides, pharmaceutical compositions comprising same and uses thereof
WO2012017439A2 (en) * 2010-08-04 2012-02-09 Ramot At Tel-Aviv University Ltd. Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
EA201391017A1 (ru) 2011-01-10 2014-04-30 Зинфандел Фармасьютикалз, Инк. Способы и готовые лекарственные формы для лечения болезни альцгеймера
JP2014517911A (ja) * 2011-04-11 2014-07-24 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド アディポネクチン受容体c末端フラグメント(ctf)免疫グロブリン
SG11201401422VA (en) * 2011-10-27 2014-09-26 Genmab As Production of heterodimeric proteins
DE102015201100B4 (de) * 2015-01-22 2018-05-17 Friedrich-Alexander-Universität Erlangen-Nürnberg Antivirale Mittel

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US20020173474A1 (en) 1993-02-12 2002-11-21 President And Fellows Of Harvard College Methods & materials involving dimerization-mediated regulation of biological events
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
JP3538711B2 (ja) 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
CA2323638A1 (en) 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000056934A1 (en) 1999-03-24 2000-09-28 Packard Bioscience Company Continuous porous matrix arrays
US20040067490A1 (en) 2001-09-07 2004-04-08 Mei Zhong Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2382015A1 (en) 1999-08-17 2001-02-22 Incyte Genomics, Inc. Membrane associated proteins
AU2001274888A1 (en) 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US20020102617A1 (en) 2000-08-03 2002-08-01 Macbeath Gavin Protein microarrays
EP1379554A2 (en) 2001-02-21 2004-01-14 Curagen Corporation Proteins, polynucleotides encoding them and methods of using the same
US20020132773A1 (en) 2001-03-14 2002-09-19 Oklahoma Medical Research Foundation Methods for reducing fat by administration of adiponectin
US20030083261A1 (en) 2001-04-30 2003-05-01 Hongtao Yu Class of 12mer peptides that inhibit the function of the mitotic check point protein Mad2
DK1426764T3 (da) 2001-08-17 2011-06-27 Fujirebio Kk Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme
WO2004022596A1 (en) 2002-09-05 2004-03-18 Komed Co., Ltd. Monoclonal antibody against adiponectin, preparation method and use thereof
US20030153013A1 (en) 2002-11-07 2003-08-14 Ruo-Pan Huang Antibody-based protein array system
JP4347874B2 (ja) * 2002-12-29 2009-10-21 株式会社東京大学Tlo アディポネクチン受容体及びそれをコードする遺伝子
EP2141235B1 (en) 2002-12-29 2014-06-11 Toudai Tlo, Ltd. Adiponectin receptor and gene coding for the same
WO2004063711A2 (en) 2003-01-09 2004-07-29 Beth Israel Deaconess Medical Center, Inc. Use of adiponectin to diagnose and treat malignancy
EP1607742B1 (en) 2003-03-24 2011-11-23 Mitsubishi Chemical Medience Corporation Latex reagent for adiponectin analysis and method of adiponectin analysis
JP4717810B2 (ja) 2003-06-20 2011-07-06 ユニバーシティ オブ フロリダ リサーチ ファウンデーション インコーポレイテッド 1型糖尿病と2型糖尿病を識別するためのバイオマーカー
US7435808B2 (en) * 2003-06-25 2008-10-14 Bristol-Myers Squibb Company Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
ES2347562T3 (es) 2003-09-27 2010-11-02 Siemens Healthcare Diagnostics Inc. Disagnosticos y terapias para enfermedades asociados con receptor emparejado de proteina g adipor1 (adipor1).
JP2007506950A (ja) 2003-09-27 2007-03-22 バイエル・ヘルスケア・エルエルシー Gタンパク質共役受容体AdipoR2(AdipoR2)に関連する疾患の診断および治療
JP4677545B2 (ja) 2003-10-15 2011-04-27 積水メディカル株式会社 多量体アディポネクチンの分別測定方法
EP1684807B1 (en) 2003-11-07 2009-09-02 Merck & Co., Inc. Method of identifying responders to treatment with insulin sensitizers
JPWO2005084697A1 (ja) * 2004-03-04 2007-11-29 門脇 孝 アディポネクチン受容体発現制御剤
GB0426798D0 (en) 2004-12-07 2005-01-12 Emtelle Uk Ltd Optical fibre tube and method of manufacturing same
US8093017B2 (en) 2005-12-07 2012-01-10 Siemens Heathcare Diagnostics Inc. Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
CN101932728B (zh) * 2007-11-30 2013-06-19 西门子医疗保健诊断公司 脂连蛋白受体片段和使用方法
WO2010123720A1 (en) 2009-04-23 2010-10-28 Siemens Healthcare Diagnostics Inc. Monomeric and dimeric forms of adiponectin receptor fragments and methods of use

Similar Documents

Publication Publication Date Title
JP2012524902A5 (https=)
Dobner et al. A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling
Léobon et al. Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction
JP2016106135A5 (https=)
XIANG Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction
CN102154253A (zh) 具有抑制血小板凝集功能的微小纤溶酶原突变体及其制备方法和用途
AU767827B2 (en) Fibrinolytically active polypeptide
JP2020511416A (ja) 冠状動脈アテローム性硬化症およびその合併症を治療するための方法
US20190365871A1 (en) Drug for preventing and treating osteoporosis and uses thereof
JP2017500316A5 (https=)
JP2020512288A (ja) 組織器官の繊維化を予防及び治療するための方法
EP3079711A1 (en) Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
RU2419629C2 (ru) ИНГИБИТОР Bst2
CN108834417A (zh) 具有抗炎症活性的肽及其用途
CN116507733A (zh) 共表达cxcr4和il-10的间充质干细胞及其用途
CN105101990B (zh) 胰岛素分泌多肽
JP2014519514A5 (https=)
EP2328925A1 (en) Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
JP2002345468A5 (https=)
US20220241374A1 (en) Treatment of non-alcoholic steatohepatitis
CN108210893A (zh) 预防和治疗肾纤维化的药物及其用途
CN103641905B (zh) 干扰素α1b突变体及其与人血清白蛋白的融合蛋白
JP4520951B2 (ja) インスリン分泌誘導剤及びインスリン分泌誘導組成物
CN1324132C (zh) 一种蛇毒类凝血酶及其编码基因与应用
Nocera et al. Heparin Induced Thrombocytopenia (HIT) in patients with ventricular assistance device bridge-to-transplantation: a case series